CPHI Milan newsletter
PCI High Potent Manufacturing
LB Bohle – 10.06.2025
Temax_Krautz

Current Edition

Current Edition

CDMO Subsection

Insights into the latest developments in CDMO services and manufacturing.

Continue reading

Injectables Subsection

Expert perspectives on the evolving needs of injectable therapies and packaging.

Continue reading

Nasal & Pulmonary Subsection

Exploring the latest developments in inhalation technologies, respiratory delivery and sustainability

Continue reading

Advertisement

CPHI Milan
DDL 2026

Advertisement

Nipro August 26

Advertisement

Merxin March 2026

Advertisement

Aurisco 300×250

Advertisement

Lifecore Biomedical

Advertisement

Solstice

An Insider’s Guide to Reaching a Right-the-First-Time Technical Transfer

Many tech transfers look fine on paper. The package is complete, both teams are experienced, and the process has run cleanly for years. But then the engineering run tells you something nobody expected. “Often, the unexpected happens with something the prior team discovered years ago and never wrote down,” says Ryan Swanson, Director of Manufacturing Science and Technology (MS&T) at Lifecore Injectables CDMO. “Those details aren’t included in a handoff, and they can show up in an engineering run when it’s expensive to fix.”

To assist sponsors in minimizing tech transfer risk, Lifecore has published a five-part guide on what separates the transfers that go right the first time from the ones that don’t. The series works through five areas where gaps tend to form: knowledge sharing, commercial scale-up, equipment planning, method transfer, and team dynamics.

Get the Insider’s Guide to prepare for your next transfer: www.lifecore.com/techtransfer

Advertisement

MedPharm 16/07

Advertisement

Biopharma group march 2026

Advertisement

Silgan March 2026

Advertisement

Terumo 06/26

Advertisement

Scott Pharma – 25.03.2025

Advertisement

Bespak

Advertisement

Tjoapack
Aptar – 08/01/2026